• Medientyp: E-Artikel
  • Titel: The last year of life for patients dying from cancer vs. non-cancer causes: a retrospective cross-sectional survey of bereaved relatives
  • Beteiligte: Kasdorf, Alina; Dust, Gloria; Hamacher, Stefanie; Schippel, Nicolas; Rietz, Christian; Voltz, Raymond; Strupp, Julia; Pfaff, Holger; Albus, Christian; Ansmann, Lena; Jessen, Frank; Karbach, Ute; Kuntz, Ludwig; Schubert, Ingrid; Schulz- Nieswandt, Frank; Stock, Stephanie
  • Erschienen: Springer Science and Business Media LLC, 2022
  • Erschienen in: Supportive Care in Cancer
  • Sprache: Englisch
  • DOI: 10.1007/s00520-022-06908-8
  • ISSN: 0941-4355; 1433-7339
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To compare health care experiences of patients with cancer or non-cancer diseases in their last year of life.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>A cross-sectional post-bereavement survey was conducted using an adapted German version of the VOICES questionnaire (VOICES-LYOL-Cologne). Differences in the reported experiences were assessed using a two-sided Pearson’s chi-square test and Mann–Whitney <jats:italic>U</jats:italic> test.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>We collected data from 351 bereaved relatives. More than half of non-cancer patients were not informed that their disease could lead to death (<jats:italic>p</jats:italic> &lt; 0.001). When this was communicated, in 46.7% of non-cancer and 64.5% of cancer patients, it was reported by the hospital doctor (<jats:italic>p</jats:italic> = 0.050). In all, 66.9% of non-cancer and 41.6% of cancer patients were not informed about death being imminent (<jats:italic>p</jats:italic> &lt; 0.001). On average, non-cancer patients had significantly fewer transitions and hospital stays in their last year of life (<jats:italic>p</jats:italic> = 0.014; <jats:italic>p</jats:italic> = 0.008, respectively). Non-cancer patients were treated more often by general practitioners, and cancer patients were treated more often by specialists (<jats:italic>p</jats:italic> = 0.002; <jats:italic>p</jats:italic> = 0.002, respectively). A substantially lower proportion of non-cancer patients were treated by at least one member of or in the setting of general or specialized palliative care (<jats:italic>p</jats:italic> &lt; 0.001).</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Non-cancer patients experience disadvantages in communication regarding their care and in access to specialized palliative care in their last year of life compared to cancer patients. Regarding the assessment of palliative care needs and the lack of communication of an incurable disease, non-cancer patients are underserved. An early identification of patients requiring palliative care is a major public health concern and should be addressed irrespective of diagnosis.</jats:p> </jats:sec><jats:sec> <jats:title>Trial registration</jats:title> <jats:p>Prospectively registered by the German Clinical Trials Register (DRKS00011925, data of registration: 13.06.2017).</jats:p> </jats:sec>